56 related articles for article (PubMed ID: 32278208)
1. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
Huang WY; Zhang XR; Lyu L; Wang SQ; Zhang XT
Bioorg Chem; 2020 Jun; 99():103814. PubMed ID: 32278208
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of novel benzo[6,7]indolo[3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition.
Sakai K; Soshima T; Hirose Y; Ishibashi F; Hirao S
Bioorg Med Chem Lett; 2024 May; 104():129710. PubMed ID: 38518997
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and preliminary structure-activity relationship study of 3-methylquinazolinone derivatives as EGFR inhibitors with enhanced antiproliferative activities against tumour cells.
Zhang Y; Wang Q; Li L; Le Y; Liu L; Yang J; Li Y; Bao G; Yan L
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1205-1216. PubMed ID: 34074193
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I.
Elsayed MSA; Su Y; Wang P; Sethi T; Agama K; Ravji A; Redon CE; Kiselev E; Horzmann KA; Freeman JL; Pommier Y; Cushman M
J Med Chem; 2017 Jul; 60(13):5364-5376. PubMed ID: 28657311
[TBL] [Abstract][Full Text] [Related]
5. The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor.
Yu Q; Chen Y; Yang H; Zhang HL; Agama K; Pommier Y; An LK
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):818-822. PubMed ID: 30907213
[TBL] [Abstract][Full Text] [Related]
6. Rational design and synthesis of novel quinazolinone N-acetohydrazides as type II multi-kinase inhibitors and potential anticancer agents.
Abd El-Karim SS; Syam YM; El Kerdawy AM; Abdel-Mohsen HT
Bioorg Chem; 2024 Jan; 142():106920. PubMed ID: 37898082
[TBL] [Abstract][Full Text] [Related]
7. QSAR prediction, synthesis, anticancer evaluation, and mechanistic investigations of novel sophoridine derivatives as topoisomerase I inhibitors.
Zhu L; Yu Y; Ma Y; Shi Y; Kowah JAH; Wang L; Yuan M; Liu X
Fitoterapia; 2024 Jun; 175():105921. PubMed ID: 38561052
[TBL] [Abstract][Full Text] [Related]
8. Identification of FTY720 and COH29 as novel topoisomerase I catalytic inhibitors by experimental and computational studies.
Zeng H; Zhang S; Nie H; Li J; Yang J; Zhuang Y; Huang Y; Zeng M
Bioorg Chem; 2024 Jun; 147():107412. PubMed ID: 38696845
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and in vitro anticancer activity of some new lomefloxacin derivatives.
Adly ME; Gedawy EM; El-Malah AA; Khalil OM
Sci Rep; 2024 Mar; 14(1):6175. PubMed ID: 38485748
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Investigation of the Pharmacokinetics and Anticancer Activities of Indenoisoquinoline Derivatives That Stabilize the G-Quadruplex in the
Han Y; Buric A; Chintareddy V; DeMoss M; Chen L; Dickerhoff J; De Dios R; Chand P; Riggs R; Yang D; Cushman M
J Med Chem; 2024 May; 67(9):7006-7032. PubMed ID: 38668707
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Anticancer Evaluation of Substituted Cinnamic Acid Bearing 2-Quinolone Hybrid Derivatives.
Abu Almaaty AH; Elgrahy NA; Fayad E; Abu Ali OA; Mahdy ARE; Barakat LAA; El Behery M
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443308
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB.
Soren BC; Babu Dasari J; Ottaviani A; Messina B; Andreotti G; Romeo A; Iacovelli F; Falconi M; Desideri A; Fiorani P
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299074
[TBL] [Abstract][Full Text] [Related]
13. Development of novel quinoline-NO donor hybrids inducing human breast cancer cells apoptosis via inhibition of topoisomerase I.
Wu G; Zhong H; Wang Y; Chen L; Sun J
Bioorg Med Chem; 2023 Dec; 96():117530. PubMed ID: 37956506
[TBL] [Abstract][Full Text] [Related]
14. Overview of the New Bioactive Heterocycles as Targeting Topoisomerase Inhibitors Useful Against Colon Cancer.
Santos MB; de Azevedo Teotônio Cavalcanti M; de Medeiros E Silva YMS; Dos Santos Nascimento IJ; de Moura RO
Anticancer Agents Med Chem; 2024; 24(4):236-262. PubMed ID: 38038012
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis of Novel 1,2,3-Triazole Pendent Quinazolinones and Their Cytotoxicity against MCF-7 Cell Line.
Myakala N; Kandula K; Rayala N; Kuna S; Thumma V; Durga Bhavani Anagani K
Chem Biodivers; 2023 Dec; 20(12):e202300800. PubMed ID: 37708234
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterisation of (Z)-styrylbenzene derivatives as potential selective anticancer agents.
Xin YB; Li JJ; Zhang HJ; Ma J; Liu X; Gong GH; Tian YS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1554-1564. PubMed ID: 30244610
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of harmine derivatives as topoisomerase I inhibitors for cancer treatment.
Guo YL; Yu JW; Cao Y; Cheng KX; Dong-Zhi SN; Zhang YF; Ren QJ; Yin Y; Li CL
Eur J Med Chem; 2024 Feb; 265():116061. PubMed ID: 38154256
[TBL] [Abstract][Full Text] [Related]
18. Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB.
Ottaviani A; Iacovelli F; Fiorani P; Desideri A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923641
[TBL] [Abstract][Full Text] [Related]
19. Study of nitrogen heterocycles as DNA/HSA binder, topoisomerase inhibitors and toxicological safety.
Dos Santos JC; Alves JEF; de Azevedo RDS; de Lima ML; de Oliveira Silva MR; da Silva JG; da Silva JM; de Carvalho Correia AC; do Carmo Alves de Lima M; de Oliveira JF; de Moura RO; de Almeida SMV
Int J Biol Macromol; 2024 Jan; 254(Pt 3):127651. PubMed ID: 37949265
[TBL] [Abstract][Full Text] [Related]
20. Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.
Tiwari PB; Chapagain PP; Seddek A; Annamalai T; Üren A; Tse-Dinh YC
ChemMedChem; 2020 Apr; 15(7):623-631. PubMed ID: 32043806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
